ACS, OMI/STEMI Equivalents & Reperfusion

A. Prioritized Bedside Diagnostic Modalities

1. 12-Lead, Right-Sided (V₄R), and Posterior (V₇–V₉) Electrocardiography:
   • Why Chosen: Immediately identifies epicardial coronary occlusion requiring emergent mechanical or pharmacological reperfusion at the bedside within 10 minutes [1,2].
   • Blind Spots & Limitations: Classic millimeter-based STEMI criteria (≥ 1 mm ST-elevation in 2 contiguous leads; ≥ 2 mm in men ≥ 40 y in V₂–V₃, ≥ 2.5 mm in men under 40 y, or ≥ 1.5 mm in women in V₂–V₃) have a sensitivity of only 45–50% for acute coronary occlusion (OMI) [3]. Up to 25–30% of patients categorized as "NSTEMI" have a completely occluded culprit artery (frequently the Left Circumflex [LCx] or diagonal/obtuse marginal branches) at angiography [3]. Serial ECGs every 15 minutes are mandatory when clinical suspicion persists despite an initially nondiagnostic tracing [1,2].
2. High-Sensitivity Cardiac Troponin I or T (hs-cTnI / hs-cTnT) with 0h/1h or 0h/2h Accelerated Diagnostic Protocols (ADP):
   • Why Chosen: Detects femtomolar concentrations of myocardial structural injury with > 99% negative predictive value (NPV) when integrated into the ESC 0h/1h or 0h/2h algorithm alongside the HEART Score or EDACS [1,2].
   • Blind Spots & Limitations: Troponin rises only after sarcolemmal disruption; free cytosolic pool release takes 1–3 hours even with high-sensitivity assays. Never delay Cath Lab activation for troponin results in a patient with STEMI or an OMI ECG pattern [1,2]. Furthermore, hs-cTn cannot distinguish Type 1 MI (atherothrombotic plaque rupture) from Type 2 MI (supply-demand mismatch from sepsis, tachyarrhythmia, GI bleed, or pulmonary embolism) or non-ischemic myocardial injury (myocarditis, renal failure, contusion) [1,2].
3. Point-of-Care Ultrasound (POCUS — Parasternal Long/Short Axis, Apical 4-Chamber, Subxiphoid):
   • Why Chosen: Regional wall motion abnormalities (RWMAs) occur at Step 3 of the ischemic cascade—before surface ECG ST-elevation or troponin elevation [1,2]. POCUS simultaneously screens for life-threatening STEMI mimics: Type A Aortic Dissection (suprasternal/parasternal aortic root > 4.0 cm with intimal flap or pericardial effusion), Massive Pulmonary Embolism (RV dilation with RV:LV ratio > 1.0, McConnell sign, D-sign flattening of the interventricular septum), and Mechanical MI Complications (papillary muscle rupture with acute severe mitral regurgitation, ventricular septal rupture, or free-wall rupture with tamponade) [1,2].
   • Blind Spots & Limitations: Cannot differentiate an acute RWMA from a chronic scar unless thin, hyperechoic scarred myocardium (< 6 mm diastolic thickness) is clearly visible.

B. High-Yield OMI Equivalents & Electrocardiographic Localization Matrix

A. Master Therapeutic & Escalation Table

B. Crash-Cart Mixing & Drip-Titration Box (Arithmetically Verified)

ARITHMETICALLY VERIFIED BEDSIDE INFUSION RECIPES

1. Nitroglycerin (GTN) Continuous IV Infusion (Standard Premix or Bedside Mix):

   • Mixing Recipe: Add 50 mg of Nitroglycerin (10 mL of 5 mg/mL vial) into a 250 mL glass or non-PVC polyolefin bag of D₅W or 0.9% NaCl (total volume 250 mL after withdrawing 10 mL).
   • Final Concentration: 50,000 mcg / 250 mL = 200 mcg/mL.
   • Pump Rate Formula: Rate (mL/hr) = [Dose (mcg/min) × 60 min/hr] / 200 mcg/mL = 0.3 × Dose (mcg/min).
   • Titration Ladder: 10 mcg/min = 3 mL/hr • 20 mcg/min = 6 mL/hr • 50 mcg/min = 15 mL/hr • 100 mcg/min = 30 mL/hr • 200 mcg/min = 60 mL/hr.

2. Unfractionated Heparin (UFH) Weight-Based ACS Infusion (Standard Concentration):

   • Mixing Recipe: Add 25,000 Units of UFH into a 250 mL bag of 0.9% NaCl or D₅W → Final Concentration = 100 Units/mL.
   • ACS Bolus (60 Units/kg, Max 4,000 Units): For an 80 kg patient, 60 × 80 = 4,800 Units → Cap at ceiling dose of 4,000 Units (40 mL from bag or 0.8 mL of 5,000 Units/mL vial) IV push.
   • ACS Infusion (12 Units/kg/hr, Max 1,000 Units/hr): For an 80 kg patient, 12 × 80 = 960 Units/hr → 960 / 100 = 9.6 mL/hr (For any patient ≥ 83.3 kg, cap at 1,000 Units/hr = 10.0 mL/hr). Check aPTT at 6 hours (target 1.5–2.0× control, or 50–70 seconds) [1,2].

3. Norepinephrine Infusion (First-Line Vasopressor for ACS-Induced Cardiogenic Shock):

   • Mixing Recipe: Add 4 mg of Norepinephrine (4 mL of 1 mg/mL ampule) into 250 mL of D₅W (prevents oxidative degradation) → Final Concentration = 4,000 mcg / 250 mL = 16 mcg/mL.
   • Titration Ladder: 2 mcg/min = 7.5 mL/hr • 5 mcg/min = 18.75 mL/hr • 10 mcg/min = 37.5 mL/hr • 20 mcg/min = 75.0 mL/hr.

4. Esmolol Infusion (For Refractory Sympathetic Tachycardia/Hypertension with Preserved LV Function):

   • Mixing Recipe: Premixed 2,500 mg in 250 mL (0.9% NaCl) → Final Concentration = 10 mg/mL (10,000 mcg/mL).
   • Loading Bolus (500 mcg/kg IV over 1 min): For an 80 kg patient = 40 mg = 4 mL IV push.
   • Maintenance Infusion (50–200 mcg/kg/min): For an 80 kg patient at 50 mcg/kg/min = (50 × 80 × 60) / 10,000 = 24 mL/hr.

C. The Refractory Crashing Patient (Minute 15–30 Salvage & Resource-Limited Bailouts)

1. Refractory Ventricular Fibrillation / Electrical Storm in Acute OMI:
   • If VF persists after 3 standard biphasic shocks (200 J), Epinephrine 1 mg IV, and Amiodarone 300 mg IV (followed by 150 mg IV) or Lidocaine 1.5 mg/kg IV, acute ischemic sympathetic overdrive is perpetuating phase 2 re-entry.
   • Step 1 (Vector-Change / Double Sequential External Defibrillation [DSED]): Apply a second set of pads in the anterior-posterior position and deliver two sequential 200 J shocks separated by < 1 second (DOSE VF trial).
   • Step 2 (Sympathetic Blockade): Administer Esmolol 500 mcg/kg IV bolus over 1 minute followed by 50 mcg/kg/min infusion (or Propranolol 1 mg IV over 1 min q5min up to 3–5 mg) to extinguish myocardial β₁-mediated intracellular Ca²⁺ overload and ventricular ectopy.
   • Step 3 (ECPR / Mechanical Circulatory Support to Cath Lab): Activate veno-arterial ECMO (VA-ECMO) or mechanical CPR (LUCAS) as a direct bridge to emergent coronary angiography and culprit vessel stenting [1,2].
2. Failed Fibrinolysis & Rescue PCI (Resource-Limited / Non-PCI Center Bailout):
   • When a patient receives Tenecteplase at a spoke hospital because transfer to a PCI center exceeds 120 minutes, perform a repeat 12-lead ECG at 60 to 90 minutes post-lysis [1,2].
   • Failure of Reperfusion Criteria: < 50% resolution of ST-segment elevation in the single lead with the highest baseline ST-elevation, persistent ischemic chest pain, or hemodynamic/electrical instability [1,2].
   • Action: Immediately transfer for Rescue PCI [1,2]. Never repeat a second full dose of fibrinolytics (doubles intracranial hemorrhage without improving patency). Even if fibrinolysis succeeds (≥ 50% ST-resolution), transfer all patients to a PCI center for routine pharmacoinvasive angiography between 2 and 24 hours post-lysis [1,2].
3. Right Ventricular (RV) Infarction Crashing after Inadvertent Nitrate/Diuretic Administration:
   • Proximal RCA occlusion causes acute RV systolic failure; the thin-walled RV relies entirely on passive preload and intact interventricular septal contraction to push blood across the pulmonary vascular bed into the left atrium.
   • Bailout: Immediately stop all nitrates/opioids. Infuse 0.9% NaCl or Ringer's Lactate 500–1,000 mL IV bolus (carefully monitoring for lung rales; stop if CVP > 15 mmHg or PCWP rises without cardiac output improvement, as excessive RV dilation shifts the interventricular septum leftward via ventricular interdependence, crushing LV filling) [1,2]. Start Norepinephrine (2–20 mcg/min) to restore aortic root diastolic pressure (which perfuses the RCA) and Dobutamine (2.5–10 mcg/kg/min) for RV inotropy. If high-grade AV block or loss of atrial kick occurs (which provides up to 35% of RV stroke volume), initiate AV-sequential transvenous pacing [1,2].

D. Vulnerable Physiological Extremes Matrix (Pregnancy, Pediatrics & Geriatrics)

⚠ E. "NEVER DO THIS & WHY" (Pathophysiological & Mechanical Counter-Examples)

5 LETHAL CLINICAL ERRORS IN ACUTE CORONARY SYNDROME MANAGEMENT

1. NEVER administer early intravenous Beta-Blockers (e.g., Metoprolol 5 mg IV × 3) to an ACS patient with tachycardia, Killip Class II–IV heart failure (pulmonary rales), PR interval > 0.24 s, or SBP < 120 mmHg: Why It Kills (COMMIT/CCS-2 Trial Mechanism): In acute anterior STEMI with large myocardial jeopardy, compensatory sinus tachycardia is the only mechanism maintaining Cardiac Output (CO = HR × SV) in the face of a fixed, plummeting Stroke Volume (SV). Acute β₁-blockade obliterates this compensatory tachycardia and blunts contractility in the remaining viable myocardium, precipitating fatal cardiogenic shock (30% relative increase in shock in the first 24 hours in the COMMIT trial), completely negating the reduction in ventricular fibrillation [1,2].
2. NEVER administer Nitrates (Sublingual or IV), Morphine, or Furosemide in an Inferior STEMI before obtaining a Right-Sided ECG (V₄R) or POCUS to exclude Right Ventricular (RV) Infarction (or within 24–48 hours of PDE-5 inhibitor use): Why It Kills: Up to 40% of inferior STEMIs involve proximal RCA occlusion affecting the RV marginal branches. The acutely ischemic RV acts as a passive conduit whose stroke volume depends entirely on systemic venous return (preload). Venodilators (Nitrates, Morphine) and loop diuretics (Furosemide) pool blood in the splanchnic/peripheral capacitance veins, causing catastrophic loss of RV preload, collapse of LV filling, and refractory hypotension. If Sildenafil/Vardenafil was taken within 24 hours (or Tadalafil within 48 hours), PDE-5 inhibition blocks the degradation of cGMP, causing synergistic, irreversible vasoplegic shock when paired with nitrate-derived NO [1,2].
3. NEVER mistake Isolated Anterior ST-Segment Depression (V₁–V₃) for "Anterior Subendocardial Ischemia / NSTEMI" and withhold emergent Cath Lab activation: Why It Kills: Subendocardial ischemia does not localize to V₁–V₃ (it manifests maximally in the apical/lateral leads V₄–V₆, I, II with reciprocal STE in aVR). Horizontal or flat ST-depression maximal in V₁–V₃ is the reciprocal mirror of an Acute Transmural Posterior OMI (LCx or RCA occlusion) [1,2,3]. Placing posterior leads V₇–V₉ reveals ≥ 0.5 mm ST-elevation [1,2]. Treating this as NSTEMI delays reperfusion by 24–48 hours, resulting in posteromedial papillary muscle necrosis and severe mitral regurgitation.
4. NEVER administer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs — Ibuprofen, Ketorolac, Diclofenac) or Corticosteroids for ischemic or post-infarction pericarditic chest pain: Why It Kills: NSAIDs (except low-dose aspirin) inhibit COX-2-mediated endothelial Prostacyclin (PGI₂) synthesis while leaving COX-1 TXA₂ unopposed, promoting coronary thrombosis. More critically, both NSAIDs and corticosteroids inhibit fibroblast migration and collagen cross-linking in the necrotic infarct zone, causing infarct expansion, myocardial scar thinning, and fatal Left Ventricular Free-Wall Rupture [1,2].
5. NEVER administer routine Intravenous Morphine to every ACS patient with mild-to-moderate chest pain before maximizing anti-ischemic therapy (Nitrates): Why It Kills (CRUSADE Registry & ATLANTIC Pharmacokinetic Interaction): Morphine binds μ-opioid receptors in the enteric nervous system (myenteric plexus), causing gastroparesis and pyloric sphincter spasm. This delays the intestinal absorption and peak plasma concentration of oral P2Y₁₂ inhibitors (Ticagrelor, Prasugrel, Clopidogrel) by 2 to 4 hours, increasing early stent thrombosis and infarct size [1,2].

A. Disposition & ICU Escalation Criteria

• Immediate Cardiac Catheterization Laboratory & Coronary Care Unit (CCU / Cardiac ICU): All patients with STEMI, New LBBB with positive Modified Sgarbossa Criteria, or High-Risk OMI Equivalents (De Winter, Posterior MI, Hyperacute T-waves, Shark Fin) [1,2]. Also includes Very High-Risk NSTE-ACS (Immediate Invasive Strategy < 2 hours): hemodynamic instability or cardiogenic shock, refractory or recurrent chest pain despite maximal medical therapy, life-threatening arrhythmias (VF/VT or high-grade AV block), mechanical complications of MI, acute heart failure clearly secondary to ongoing ischemia, or dynamic ST-depression > 1 mm in ≥ 6 leads plus ST-elevation in aVR and/or V₁ [1,2].
• Inpatient Telemetry / Step-Down Admission (Early Invasive Strategy < 24 hours): Confirmed High-Risk NSTEMI: Elevated hs-cTn above the 99th percentile URL with a significant rise/fall (Δ), dynamic contiguous ST-segment or T-wave changes (including Wellens Syndrome), transient ST-elevation, or a GRACE Score > 140 [1,2].
• Observation / Chest Pain Unit or Safe Direct ED Discharge: Patients with normal serial 12-lead ECGs, no high-risk OMI features, HEART Score 0–3 (or EDACS < 16), and negative 0h/1h (or 0h/2h) hs-cTn delta have a 30-day Major Adverse Cardiac Event (MACE) rate of < 0.5–1.0% and can be safely discharged with outpatient cardiology follow-up within 72 hours [1,2].

B. Program Director's Quality KPIs, Accreditation (JCI / CBAHI / GAHAR / Ada'a) & M&M Audit Points

• Door-to-ECG Time: ≤ 10 minutes from ED arrival/triage registration for any patient presenting with chest pain, epigastric pain, dyspnea, syncope, or diaphoresis (Target compliance: ≥ 90% per Saudi MoH Ada'a, CBAHI, and JCI standards) [1,2].
• Door-to-Needle Time (Fibrinolysis in Non-PCI Capable Centers): ≤ 30 minutes (ESC target: ≤ 10 minutes from STEMI diagnosis) [1,2].
• First Medical Contact (FMC)-to-Device / Door-to-Balloon (D2B) Time: Primary PCI-capable hospital: ≤ 90 minutes (ESC target: ≤ 60 minutes from STEMI diagnosis). Inter-facility transfer from non-PCI spoke to PCI hub: ≤ 120 minutes total FMC-to-device time (with Door-In-Door-Out [DIDO] time ≤ 30 minutes at the referring ED) [1,2].
• Mandatory Medicolegal Charting Points (M&M Prevention): (1) Exact time-stamped interpretation of serial ECGs (including V₄R in inferior MI and V₇–V₉ in anterior ST-depression); (2) Explicit screening and documentation of Absolute and Relative Contraindications to Fibrinolysis and Bilateral Blood Pressures + Mediastinal/Aortic POCUS prior to heparin/lysis; (3) Documentation of absence of PDE-5 inhibitor intake within 24–48 hours prior to nitrate administration.

C. Structured Clinical SBAR Handover (ED Consultant to Interventional Cardiology Consultant)

A. OSCE & Oral Board Examiner Rubric (4 Mandatory Pass Actions)

1. Immediate Recognition & Extended Lead Acquisition (≤ 10 min): Orders and interprets the 12-lead ECG within 60 seconds of station start, explicitly identifying classic STEMI or OMI equivalents and ordering V₄R (for inferior changes) or V₇–V₉ (for anterior ST-depression) before administering preload-reducing agents.
2. Pre-Treatment Safety Screen (Dissection & Contraindications): Evaluates bilateral upper-extremity blood pressures/pulses, performs a focused bedside POCUS (aortic root, pericardium, RV/LV wall motion), and explicitly asks about PDE-5 inhibitor use (before nitrates) and fibrinolytic/anticoagulation contraindications.
3. Time-Critical Reperfusion Selection & Exact Weight-Based Antithrombotic Dosing: Correctly chooses Primary PCI (if FMC-to-device ≤ 120 min) vs. Tenecteplase (if > 120 min), verbalizing exact doses including age-based (≥ 75 y) and ceiling adjustments (UFH max 4,000–5,000 U bolus, Enoxaparin no IV bolus & 0.75 mg/kg in ≥ 75 y).
4. Hemodynamic-Specific Management of Complications: Withholds IV beta-blockers in the presence of tachycardia, hypotension, or pulmonary edema (Killip II–IV), and manages RV infarction or electrical storm using pathophysiologically sound interventions (crystalloid preload / norepinephrine / DSED).

B. 2 Board-Style Clinical Vignette MCQs (SCFHS / MRCEM / ABEM Level)

Vignette 1: A 78-year-old man (72 kg) presents to a remote community emergency department with 90 minutes of severe substernal chest pain radiating to his left jaw. The nearest cardiac catheterization laboratory is 3.5 hours away by air ambulance due to weather delays. Vital signs are: BP 136/82 mmHg in both arms, HR 84 bpm, RR 18/min, and SpO₂ 96% on room air. His 12-lead ECG demonstrates 3.5 mm ST-segment elevation in leads V₁–V₄. He has no history of stroke, recent surgery, active bleeding, or oral anticoagulant use. Point-of-care ultrasound shows a normal aortic root and anterior wall akinesis. In addition to chewed aspirin 325 mg PO, which of the following is the most appropriate initial pharmacological reperfusion and antithrombotic regimen for this patient?

• A. Tenecteplase 40 mg IV bolus, Ticagrelor 180 mg PO, and Enoxaparin 30 mg IV bolus followed by 72 mg SC q12h
• B. Tenecteplase 20 mg IV bolus, Clopidogrel 75 mg PO, and Enoxaparin 54 mg SC q12h (with no IV bolus)
• C. Tenecteplase 40 mg IV bolus, Clopidogrel 300 mg PO, and Unfractionated Heparin 5,000 Units IV bolus followed by 1,200 Units/hr
• D. Alteplase 100 mg IV over 90 minutes, Prasugrel 60 mg PO, and Fondaparinux 2.5 mg SC once

Correct Answer: B.

Mechanism & Clinical Rationale: Because this patient has an acute anterior STEMI and cannot reach a PCI center within 120 minutes, fibrinolysis is indicated [1,2]. However, because the patient is ≥ 75 years old (78 years), full-dose fibrinolytics, loading doses of clopidogrel, and IV boluses of enoxaparin carry an unacceptably high risk of fatal intracranial hemorrhage (ICH) due to cerebral amyloid angiopathy and reduced renal clearance. Based on the STREAM trial and ExTRACT-TIMI 25 trial (and 2023 ESC / 2025 ACC/AHA Guidelines), three mandatory geriatric modifications apply to patients ≥ 75 years: (1) Half-dose Tenecteplase: For a 72 kg patient, the standard dose is 40 mg; reducing by 50% yields 20 mg IV bolus [1,2]; (2) Clopidogrel without a 300-mg load: Give 75 mg PO [1,2]; (3) Enoxaparin without an IV bolus at 0.75 mg/kg SC q12h: 0.75 mg/kg × 72 kg = 54 mg SC q12h (capped at 75 mg for the first two doses) [1,2]. Why Distractors Fail: Choice A uses full-dose TNK, full-dose Enoxaparin with an IV bolus, and Ticagrelor. Choice C fails to reduce TNK/Clopidogrel for age ≥ 75 y and exceeds the maximum UFH fibrinolysis ceiling (4,000 U bolus / 1,000 U/hr infusion). Choice D uses Prasugrel (contraindicated in fibrinolysis and generally avoided in age ≥ 75 y).

Vignette 2: A 51-year-old woman presents to the ED with 40 minutes of acute retrosternal chest pressure, nausea, and diaphoresis. Vital signs are: BP 124/78 mmHg, HR 90 bpm, RR 16/min, and SpO₂ 98% on room air. Her initial 12-lead ECG shows no ST-segment elevation in any of the 12 standard leads; however, leads V₁, V₂, and V₃ demonstrate 2 mm of flat horizontal ST-segment depression, accompanied by a tall, broad R-wave in V₂ (R/S ratio = 1.5) and upright T-waves. Leads V₅ and V₆ have isoelectric ST-segments. What is the most accurate pathophysiological diagnosis and immediate next step in management?

• A. Subendocardial anterior ischemia (NSTEMI) due to subtotal LAD stenosis; initiate heparin infusion, order serial hs-cTn at 0h and 1h, and schedule angiography within 24 hours.
• B. Left main coronary artery subocclusion; administer ticagrelor 180 mg PO immediately and consult cardiothoracic surgery for emergent CABG.
• C. Acute transmural posterior (inferobasal) OMI due to Left Circumflex or distal RCA occlusion; immediately obtain posterior leads (V₇–V₉) and activate the cardiac catheterization lab for Primary PCI.
• D. Type A Wellens syndrome; withhold all provocative testing, admit to telemetry, and perform non-emergent inpatient coronary angiography.

Correct Answer: C.

Mechanism & Clinical Rationale: Horizontal ST-segment depression maximal in leads V₁–V₃ (with spared lateral leads V₅–V₆), paired with a tall R-wave (R/S > 1 in V₂) and upright T-waves, is the classic electrical mirror image of an Acute Isolated Posterior (Inferobasal) OMI, most commonly caused by acute occlusion of the Left Circumflex (LCx) or Posterior Descending Artery (PDA) [1,2,3]. Because the anterior precordial leads V₁–V₃ view the posterior wall from the opposite side of the thorax, posterior epicardial ST-elevation records as anterior ST-depression, posterior Q-waves record as tall anterior R-waves, and posterior hyperacute T-waves record as upright anterior T-waves. Both the 2025 ACC/AHA and 2023 ESC guidelines classify isolated posterior MI (confirmed by ≥ 0.5 mm ST-elevation in V₇–V₉) as a STEMI equivalent requiring immediate Primary PCI [1,2]. Why Distractors Fail: Choice A confuses localized V₁–V₃ ST-depression with diffuse subendocardial ischemia (maximal in V₄–V₆, I, II with STE in aVR). Choice B requires diffuse ≥ 6-lead ST-depression with STE in aVR (> V₁), and loading Ticagrelor before angiography in suspected LMCA surgical disease increases perioperative CABG bleeding. Choice D describes biphasic T-waves in V₂–V₃ in a pain-free patient without significant ST-depression or tall R-waves.